Xoft
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Xoft sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Xoft: 10 sponsored US clinical trials, none currently recruiting.
Xoft sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Ductal Carcinoma In Situ, with 2 trials.
Top-decile sponsor footprint
Xoft ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
10 total, page 1 of 1
Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
NCT01644669
Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx
NCT05257486
Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
NCT04681677
Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.
NCT03024866
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
NCT01851772
Electronic Brachytherapy for the Treatment of NMSC
NCT01016899
Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer
NCT01045187
Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer
NCT02040493
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
NCT00742222
Post Market Study Using the Xoft Axxent System
NCT01017549
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
How the Xoft archive is shaped
10 indexed studies, none listed as recruiting (0% open); 7 completed (70%).
Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).
Top condition: Ductal Carcinoma In Situ (2 trials), 7 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Xoft: archived-pipeline peers nationwide
Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Xoft sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 archived trials
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Xoft page
10 registered trials is a research-attention snapshot, not an endorsement of Xoft or any single study.
- None of Xoft's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Ductal Carcinoma In Situ is the condition Xoft studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Ductal Carcinoma In Situ trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Xoft pipeline card: 10 registered trials from official public datasets.Report a data error.